Skip to main content
. Author manuscript; available in PMC: 2024 Jan 3.
Published in final edited form as: J Am Coll Cardiol. 2022 Oct 31;81(1):16–30. doi: 10.1016/j.jacc.2022.10.008

Figure 4. Major bleeding and clinically relevant non-major bleeding.

Figure 4.

Pooled results suggest no significant difference in the rates of major bleeding (A) and CRNMB (B) between patients receiving DOACs and patients receiving VKAs. CI = confidence interval; CRNMB = clinically relevant non-major bleeding; DOACs = direct oral anticoagulants; VKAs = vitamin-K antagonists. Abbreviations as in other Figures.